Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Levels of tobacco-specific metabolites among non-smoking lung cancer cases at diagnosis: case-control findings.

Hwang SH, Ryu HJ, Kang SJ, Yun EH, Lim MK, Kim HT, Lee JS, Lee DH.

Asian Pac J Cancer Prev. 2014 Jan;14(11):6591-3.

2.

Metabolites of a tobacco-specific lung carcinogen in nonsmoking women exposed to environmental tobacco smoke.

Anderson KE, Carmella SG, Ye M, Bliss RL, Le C, Murphy L, Hecht SS.

J Natl Cancer Inst. 2001 Mar 7;93(5):378-81.

PMID:
11238699
3.
4.

Metabolites of a tobacco-specific lung carcinogen in nonsmoking casino patrons.

Anderson KE, Kliris J, Murphy L, Carmella SG, Han S, Link C, Bliss RL, Puumala S, Murphy SE, Hecht SS.

Cancer Epidemiol Biomarkers Prev. 2003 Dec;12(12):1544-6.

5.

Exposure to the carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in smokers from 3 populations with different risks of lung cancer.

Derby KS, Cuthrell K, Caberto C, Carmella S, Murphy SE, Hecht SS, Le Marchand L.

Int J Cancer. 2009 Nov 15;125(10):2418-24. doi: 10.1002/ijc.24585.

6.

Uptake of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by Moldovan children.

Stepanov I, Hecht SS, Duca G, Mardari I.

Cancer Epidemiol Biomarkers Prev. 2006 Jan;15(1):7-11.

7.

Metabolites of a tobacco-specific lung carcinogen in the urine of elementary school-aged children.

Hecht SS, Ye M, Carmella SG, Fredrickson A, Adgate JL, Greaves IA, Church TR, Ryan AD, Mongin SJ, Sexton K.

Cancer Epidemiol Biomarkers Prev. 2001 Nov;10(11):1109-16.

8.

Tobacco-specific nitrosamine exposures in smokers and nonsmokers exposed to cigarette or waterpipe tobacco smoke.

Radwan G, Hecht SS, Carmella SG, Loffredo CA.

Nicotine Tob Res. 2013 Jan;15(1):130-8. doi: 10.1093/ntr/nts099. Epub 2012 May 9.

9.

Effect of maternal tobacco smoking or exposure to second-hand smoke on the levels of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in urine of mother and the first urine of newborn.

Florek E, Piekoszewski W, Basior A, Merritt AT, Mazela J, Lechowicz W, Kornacka MK, Kramer L.

J Physiol Pharmacol. 2011 Jun;62(3):377-83.

10.

Urinary metabolites of a tobacco-specific lung carcinogen in nonsmoking hospitality workers.

Tulunay OE, Hecht SS, Carmella SG, Zhang Y, Lemmonds C, Murphy S, Hatsukami DK.

Cancer Epidemiol Biomarkers Prev. 2005 May;14(5):1283-6.

11.

Differences in the urinary metabolites of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in black and white smokers.

Richie JP Jr, Carmella SG, Muscat JE, Scott DG, Akerkar SA, Hecht SS.

Cancer Epidemiol Biomarkers Prev. 1997 Oct;6(10):783-90.

12.

Quantitation of urinary metabolites of a tobacco-specific lung carcinogen after smoking cessation.

Hecht SS, Carmella SG, Chen M, Dor Koch JF, Miller AT, Murphy SE, Jensen JA, Zimmerman CL, Hatsukami DK.

Cancer Res. 1999 Feb 1;59(3):590-6.

13.

Effects of reduced cigarette smoking on the uptake of a tobacco-specific lung carcinogen.

Hecht SS, Murphy SE, Carmella SG, Zimmerman CL, Losey L, Kramarczuk I, Roe MR, Puumala SS, Li YS, Le C, Jensen J, Hatsukami DK.

J Natl Cancer Inst. 2004 Jan 21;96(2):107-15.

PMID:
14734700
14.

Racial differences in exposure and glucuronidation of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK).

Muscat JE, Djordjevic MV, Colosimo S, Stellman SD, Richie JP Jr.

Cancer. 2005 Apr 1;103(7):1420-6.

15.

Effects of watercress consumption on metabolism of a tobacco-specific lung carcinogen in smokers.

Hecht SS, Chung FL, Richie JP Jr, Akerkar SA, Borukhova A, Skowronski L, Carmella SG.

Cancer Epidemiol Biomarkers Prev. 1995 Dec;4(8):877-84.

16.

[Determination of 4-(methylnirosamino) -4-(3-pyridyl)-1-butanol (NNA) in urine of pregnant women by means of LC/MS/MS].

Florek E, Piekoszewski W, Lechowicz W, SzymaƄska A, Kornacka MK.

Przegl Lek. 2006;63(10):926-31. Polish.

PMID:
17288186
17.

Analysis of human urine for pyridine-N-oxide metabolites of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, a tobacco-specific lung carcinogen.

Carmella SG, Borukhova A, Akerkar SA, Hecht SS.

Cancer Epidemiol Biomarkers Prev. 1997 Feb;6(2):113-20.

18.

Variation in levels of the lung carcinogen NNAL and its glucuronides in the urine of cigarette smokers from five ethnic groups with differing risks for lung cancer.

Park SL, Carmella SG, Ming X, Vielguth E, Stram DO, Le Marchand L, Hecht SS.

Cancer Epidemiol Biomarkers Prev. 2015 Mar;24(3):561-9. doi: 10.1158/1055-9965.EPI-14-1054. Epub 2014 Dec 26.

19.

Genetic variability in the metabolism of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) to 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL).

Ter-Minassian M, Asomaning K, Zhao Y, Chen F, Su L, Carmella SG, Lin X, Hecht SS, Christiani DC.

Int J Cancer. 2012 Mar 15;130(6):1338-46. doi: 10.1002/ijc.26162. Epub 2011 Aug 3.

20.

Analysis of N- and O-glucuronides of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in human urine.

Carmella SG, Le Ka KA, Upadhyaya P, Hecht SS.

Chem Res Toxicol. 2002 Apr;15(4):545-50.

PMID:
11952341

Supplemental Content

Support Center